Sökning: onr:"swepub:oai:DiVA.org:uu-339738" >
First-line treatmen...
First-line treatment selection and early monitoring patterns in chronic phase-chronic myeloid leukemia in routine clinical practice : SIMPLICITY
-
- Goldberg, Stuart L. (författare)
- Hackensack Univ, Med Ctr, John Theurer Canc Ctr, 92 Second St, Hackensack, NJ 07601 USA.
-
- Cortes, Jorge E. (författare)
- Univ Texas MD Anderson Canc Ctr, Houston, TX 77030 USA.
-
- Gambacorti-Passerini, Carlo (författare)
- Univ Milano Bicocca, San Gerardo Hosp, Monza, Italy.
-
visa fler...
-
- Hehlmann, Ruediger (författare)
- Heidelberg Univ, Mannheim, Germany.
-
- Khoury, H. Jean (författare)
- Emory Univ, Winship Canc Inst, Atlanta, GA 30322 USA.
-
- Michallet, Mauricette (författare)
- Ctr Hosp Lyon Sud, Pierre Benite, France.
-
- Paquette, Ron L. (författare)
- Univ Calif Los Angeles, Med Ctr, Los Angeles, CA 90024 USA.
-
- Simonsson, Bengt (författare)
- Uppsala universitet,Hematologi,Uppsala Univ, Uppsala, Sweden.
-
- Zyczynski, Teresa (författare)
- Bristol Myers Squibb Co, Princeton, NJ USA.
-
- Foreman, Aimee (författare)
- ICON Plc, San Francisco, CA USA.
-
- Abruzzese, Elisabetta (författare)
- S Eugenio Hosp, Rome, Italy.
-
- Andorsky, David (författare)
- Rocky Mt Canc Ctr, Boulder, CO USA.
-
- Beeker, Aart (författare)
- Spaarne Hosp, Hoofddorp, Netherlands.
-
- Cony-Makhoul, Pascale (författare)
- Ctr Hosp Annecy Genevois, Pringy, France.
-
- Hansen, Richard (författare)
- Inst Med, IDGGQ, Kaiserslautern, Germany.
-
- Lomaia, Elza (författare)
- Federal Almazov North West Med Res Ctr, St Petersburg, Russia.
-
- Olavarria, Eduardo (författare)
- Imperial Coll London, Hammersmith Hosp, London, England.
-
- Mauro, Michael J. (författare)
- Mem Sloan Kettering Canc Ctr, 1275 York Ave, New York, NY 10021 USA.
-
visa färre...
-
Hackensack Univ, Med Ctr, John Theurer Canc Ctr, 92 Second St, Hackensack, NJ 07601 USA Univ Texas MD Anderson Canc Ctr, Houston, TX 77030 USA. (creator_code:org_t)
- 2017-09-25
- 2017
- Engelska.
-
Ingår i: American Journal of Hematology. - : Wiley. - 0361-8609 .- 1096-8652. ; 92:11, s. 1214-1223
- Relaterad länk:
-
https://doi.org/10.1...
-
visa fler...
-
https://uu.diva-port... (primary) (Raw object)
-
https://onlinelibrar...
-
https://urn.kb.se/re...
-
https://doi.org/10.1...
-
visa färre...
Abstract
Ämnesord
Stäng
- Achieving successful outcomes in chronic phase-chronic myeloid leukemia (CP-CML) requires careful monitoring of cytogenetic/molecular responses (CyR/MR). SIMPLICITY (NCT01244750) is an observational study exploring tyrosine kinase inhibitor use and management patterns in patients with CP-CML receiving first-line imatinib (n = 416), dasatinib (n = 418) or nilotinib (n = 408) in the US and 6 European countries in routine clinical practice. Twelve-month follow-up data of 1242 prospective patients (enrolled October 01 2010-September 02 2015) are reported. 81% of patients had baseline comorbidities. Treatment selection was based on perceived efficacy over patient comorbidity profile. There was a predominance of imatinib-treated patients enrolled earlier in the study, with subsequent shift toward dasatinib- and nilotinib-treated patients by 2013/2014. Monitoring for either CyR/MR improved over time and was documented for 36%, 82%, and 95% of patients by 3, 6, and 12 months, respectively; 5% had no documentation of CyR/MR monitoring during the first year of therapy. Documentation of MR/CyR testing was higher in Europe than the US (P < .001) and at academic versus community practices (P = .001). Age <65 years, patients being followed at sites within Europe, those followed at academic centers and patients no longer on first-line therapy were more likely to be monitored by 12 months. SIMPLICITY demonstrates that the NCCN and ELN recommendations on response monitoring have not been consistently translated into routine clinical practice. In the absence of appropriate monitoring practices, clinical response to TKI therapy cannot be established, any needed changes to treatment strategy will thus not be implemented, and long-term patient outcomes are likely to be impacted.
Ämnesord
- MEDICIN OCH HÄLSOVETENSKAP -- Klinisk medicin -- Hematologi (hsv//swe)
- MEDICAL AND HEALTH SCIENCES -- Clinical Medicine -- Hematology (hsv//eng)
Publikations- och innehållstyp
- ref (ämneskategori)
- art (ämneskategori)
Hitta via bibliotek
Till lärosätets databas
- Av författaren/redakt...
-
Goldberg, Stuart ...
-
Cortes, Jorge E.
-
Gambacorti-Passe ...
-
Hehlmann, Ruedig ...
-
Khoury, H. Jean
-
Michallet, Mauri ...
-
visa fler...
-
Paquette, Ron L.
-
Simonsson, Bengt
-
Zyczynski, Teres ...
-
Foreman, Aimee
-
Abruzzese, Elisa ...
-
Andorsky, David
-
Beeker, Aart
-
Cony-Makhoul, Pa ...
-
Hansen, Richard
-
Lomaia, Elza
-
Olavarria, Eduar ...
-
Mauro, Michael J ...
-
visa färre...
- Om ämnet
-
- MEDICIN OCH HÄLSOVETENSKAP
-
MEDICIN OCH HÄLS ...
-
och Klinisk medicin
-
och Hematologi
- Artiklar i publikationen
-
American Journal ...
- Av lärosätet
-
Uppsala universitet